Evidence map›Paper›PMID 24344112›Full record

ArticlePediatrics2014

Association between pediatric clinical trials and global burden of disease.

Florence T Bourgeois, Karen L Olson, John P A Ioannidis, Kenneth D Mandl

Abstract read
In one paragraph

Article in Pediatrics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Challenges in conducting paediatric trials with off-patent drugs.Contemporary clinical trials communications · 2021
    Article
  9. Article
  10. Fake news and fake research: Why meta-research matters more than ever.Journal of paediatrics and child health · 2020
    Article
  11. Article
  12. Review
  13. Article
  14. Lifetime Cost of Abusive Head Trauma at Ages 0-4, USA.Prevention science : the official journal of the Society for Prevention Research · 2018
    Article
  15. Review
  16. Article
  17. A child abuse research network: Now what?Child abuse & neglect · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Florence T BourgeoisDivision of Emergency Medicine, Boston Children's Hospital, 300 Longwood Ave, Boston, MA 02115. florence.bourgeois@childrens.harvard.edu.
Karen L Olson
John P A Ioannidis
Kenneth D Mandl

Funding

Establishing Surveillance of the Pediatric Evidence Base for Drug TherapyR21HD072382 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI BOURGEOIS, FLORENCE, MANDL, KENNETH D. · 2012 to 2013
$479k
NICHD NIH HHS 1R21HD072382NICHD NIH HHS R21 HD072382
6 · The paper itself

Abstract

backgroundThe allocation of research resources should favor conditions responsible for the greatest disease burden. This is particularly important in pediatric populations, which have been underrepresented in clinical research. Our aim was to measure the association between the focus of pediatric clinical trials and burden of disease and to identify neglected clinical domains.

methodsWe performed a cross-sectional study of clinical trials by using trial records in ClinicalTrials.gov. All trials started in 2006 or after and studying patient-level interventions in pediatric populations were included. Age-specific measures of disease burden were obtained for 21 separate conditions for high-, middle-, and low-income countries. We measured the correlation between number of pediatric clinical trials and disease burden for each condition.

resultsNeuropsychiatric conditions and infectious diseases were the most studied conditions globally in terms of number of trials (874 and 847 trials, respectively), while intentional injuries (5 trials) and maternal conditions (4 trials) were the least studied. Clinical trials were only moderately correlated with global disease burden (r = 0.58, P = .006). Correlations were also moderate within each of the country income levels, but lowest in low-income countries (r = .47, P = .03). Globally, the conditions most understudied relative to disease burden were injuries (-260 trials for unintentional injuries and -160 trials for intentional injuries), nutritional deficiencies (-175 trials), and respiratory infections (-171 trials).

conclusionsPediatric clinical trial activity is only moderately associated with pediatric burden of disease, and least associated in low-income countries. The mismatch between clinical trials and disease burden identifies key clinical areas for focus and investment.

Indexed as

Cost of IllnessAdolescentChildChild, PreschoolClinical Trials as TopicCross-Sectional StudiesDeveloped CountriesDeveloping CountriesGlobal HealthHumansInfantInfant, NewbornLife TablesPediatricsRegistriesburden of diseaseclinical trialspediatric research

Identifiers

PMID24344112
PMCPMC3876184

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.